Insulin Glargine vs NPH as Basal Insulin on Glycemic Values in Hospitalized Patients: The Inova Diabetes Study
Status: Withdrawn prior to enrolment
Phase of Trial: Phase III
Latest Information Update: 08 Aug 2016
Price : $35 *
At a glance
- Drugs Insulin glargine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms INOVA Diabetes; InovaDM2
- 31 Aug 2018 Biomarkers information updated
- 03 Aug 2016 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 25 Mar 2015 Planned End Date changed from 1 Aug 2015 to 1 Apr 2016, according to ClinicalTrials.gov record.